Kyle Carver
Chief Financial Officer · 2 filings · Latest: May 28, 2026
Evommune, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
EVMN | Kyle Carver | Chief Financial Officer | May 28, 2026 | Sale | $22.84 | 18,175 | $415.1K | 59,335 | |
EVMN | Kyle Carver | Chief Financial Officer | May 28, 2026 | Option Exercise | $2.99 | 15,000 | $44.9K | 77,510 | |
EVMN | KYLE CARVER | — | May 28, 2026 | Proposed Sale | $23.34 | 25,675 | $599.3K | — |